RNA Manufacturing Solutions
-
Modular Environments For Biomanufacturing Capacity
9/16/2024
Accelerate your biomanufacturing capacity with purpose-built modules
KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.
-
Broad Scale Oligonucleotide Synthesizer For Better Production Outcomes
2/9/2023
OligoProcess covers a range of 10 to 1800 mmol and is suitable for quantities required in clinical phases and commercial production.
-
Accelerate Development With Large-Scale mRNA And LNP Production
10/16/2024
Achieve scalable purity with Vernal Biosciences' mRNA and lipid nanoparticle (LNP) large-scale production, tailored to meet the demands of your preclinical studies, including dose range finding and toxicology assessments.
-
GenVoy-ILM™ T-Cell Kits For mRNA
4/24/2025
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.
-
Toxicity Studies
2/5/2025
Utilizing statistical analysis and a proprietary metabolomics database, see how we detect and identify molecular toxicity markers, providing critical safety insights into potential drug candidates.
-
High-Performance Filtration For Optimal Life Science Workflows
9/26/2021
Pall’s high-performance filtration solutions cover every step of the life science workflow - from cell line development to clone selection, optimization, and protein analysis. Our products simplify processes, reduce risk, and accelerate laboratory throughput.
-
Your Vision. Our Pioneering Experience.
3/10/2021
PRECISION ADVANCE, a collection of interconnected services and complementary teams, uniquely focuses on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully bring cell or gene therapies to market.
-
Cell Therapy Product Characterization Services
Our cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.
-
Closed Robotic Isolator For Reduced Risk And Flexibility In Vial Filling
3/23/2023
Ensure your manufacturing projects run smoothly no matter whatever comes down your pipeline. Discover a fully automated, closed robotic isolator for reduced risk and flexibility in pharmaceutical vial filling.
-
Find Your Way To Improved mRNA Purity And Yield
3/20/2024
Explore an affinity resin designed for the purification and isolation of mRNA from in vitro transcription (IVT) manufacturing processes.